openPR Logo
Press release

Multiple Sclerosis Drugs Market Pegged for Robust Expansion During 2015 to 2021

06-21-2018 03:07 PM CET | Energy & Environment

Press release from: Persistence Market Research

Multiple Sclerosis Drugs Market Pegged for Robust Expansion

Multiple sclerosis (MS) is a nervous system disease which affects spinal cord and the brain. MS damages the myelin sheath. Myelin sheath is a term which exemplifies that material which surrounds and protects human nerve cells. This damage blocks messages between brain and the body and leads to the symptoms of MS. Some of the major symptoms of MS include thinking and memory problems, visual disturbances, problem in coordination and balancing of the body and muscle weakness.

MS affects women more than men. The disease often occurs between age group of 20-40. MS is mainly divided into four types. They are relapsing-remitting MS, progressive-relapsing MS, secondary-progressive MS and primary-progressive MS. Relapsing-remitting MS is the most common form of the disease. It accounts about 85% of the total MS cases. Secondary-progressive is associated with the initial period of relapsing-remitting disease. Approximately, 50% of people suffering with relapsing remitting MS would develop this form of the disease. Progressive-relapsing MS is rare and about 5% of the total MS cases. Primary-progressive MS accounts 10% of the total MS cases.

Request for Report Sample: https://www.persistencemarketresearch.com/samples/3647

Based on the route of drug administration, the global MS drugs market is categorized into parenteral drugs and oral drugs.

The global MS drugs market is segmented into small molecule MS drugs and biologics MS drugs. Major brands of small molecule MS drugs include Copaxone, Trimesta, Novantrone, Masitinib, Gilenya, Siponimod, Firategrast, Tecfidera and Aubagio. Some of the major biologics involved in the treatment of MS are Tysabri, Ocrelizumab, Zenapax, Arzerra, Avonex, Extavia, Rebif, Betaseron and Cinnovex. These small molecule and biologics MS drugs are mainly focused on the faster recovery from attacks and reduce progression of the disease.

In terms of geographic, North America dominates the global MS drugs market. The U.S. represents the largest market for MS drugs followed by Canada in North America. In Europe, France, Germany, Italy, Spain and the U.K. holds major share of MS drugs market. However, Asia is expected to show high growth rates in the next five years in global MS drugs market. This is due to many companies constructing their manufacturing and research facilities in the region. Developing regions have advantage over the developed regions due to low wages, availability of a large talent pool, less stringent environment and health and safety regulations. Japan, China and India are expected to be the fastest growing MS drugs markets in Asia.

Request for Report TOC: https://www.persistencemarketresearch.com/toc/3647

In recent time, high unmet need of drugs for treatment of the disease and extensive R&D pipelines are some of the major drivers of the global MS drugs market. In addition, increased research in the field of MS to develop innovative therapies has also fueled the growth of global MS drugs market.

However, patent expiry of major drugs is key restraint of global MS drugs market. In addition, stringent regulatory hurdles also obstruct the growth of global MS drugs market. Advancement in biomedical science would develop opportunity for the global MS drugs market. Increasing mergers and acquisitions between manufacturing companies and rapid product launches are some of the major trends for global MS drugs market.

Some of the major companies operating in the global MS drugs market are Bayer, GlaxoSmithKline, Teva Pharmaceutical, Novartis, Merck Serono, Sanofi, Pfizer, Abbvie, Biogen Idec, AB Science and Opexa.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA,Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Multiple Sclerosis Drugs Market Pegged for Robust Expansion During 2015 to 2021 here

News-ID: 1092749 • Views:

More Releases from Persistence Market Research

Refined Glycerin Market to Reach US$ 6.1 Bn by 2032 Driven by Expanding Applications Across Pharmaceuticals and Personal Care
Refined Glycerin Market to Reach US$ 6.1 Bn by 2032 Driven by Expanding Applicat …
➤ Overview of the Market The refined glycerin market has emerged as an essential segment within the global chemicals and bio-based ingredients industry due to its versatility and compatibility with a wide range of applications. Refined glycerin, also known as glycerol, is a colorless, odorless, and sweet-tasting liquid derived mainly from vegetable oils and animal fats. It is widely used in pharmaceuticals, personal care, food and beverage, and industrial manufacturing because
Plasmid DNA Manufacturing Market Analysis and Future Outlook Revealed by Persistence Market Research
Plasmid DNA Manufacturing Market Analysis and Future Outlook Revealed by Persist …
The global plasmid DNA manufacturing market is undergoing a transformative expansion, with its value projected to grow from US$2.1 Bn in 2024 to US$7.0 Bn by 2031, reflecting a robust CAGR of 18.4%. According to Persistence Market Research, the surge is fueled by the rising demand for gene therapies, DNA vaccines, and advanced cell therapies that require plasmid DNA (pDNA) as a critical vector. Increasing incidences of genetic disorders and
Assisted Reproductive Technology Market Trends and Insights Report by Persistence Market Research
Assisted Reproductive Technology Market Trends and Insights Report by Persistenc …
The global assisted reproductive technology (ART) market is poised for strong expansion, with its valuation projected to reach US$58.5 Bn by 2031, growing at a CAGR of 9.2% between 2024 and 2031. This rapid rise is attributed to the increasing prevalence of infertility, advancements in in vitro fertilization (IVF) and related procedures, and wider societal acceptance of fertility treatments. According to Persistence Market Research, ART adoption is further encouraged by
Lipid Nanoparticle Manufacturing Market Analysis and Forecast Report by Persistence Market Research
Lipid Nanoparticle Manufacturing Market Analysis and Forecast Report by Persiste …
The global lipid nanoparticle manufacturing market is witnessing remarkable momentum, driven by advancements in drug delivery technologies and expanding applications in RNA therapeutics. According to Persistence Market Research, the market was valued at US$814.2 million in 2023 and is projected to reach US$1.8 billion by 2031, registering a robust CAGR of 10.4% between 2024 and 2031. This growth reflects the rising demand for efficient delivery platforms for mRNA vaccines, gene

All 5 Releases


More Releases for Multiple

Mango AI's Multiple Face Swap Video Tool Changes Multiple Faces Instantly
In today's digital world, creating eye-catching and unique content is essential for standing out. The ability to swap multiple faces in a single video opens up creative possibilities, whether for personalized content, comedy or parody videos, or engaging social media posts. Mango AI, developed by Mango Animate, is excited to announce the launch of its advanced multiple face swap video (https://mangoanimate.com/ai/multiple-face-swap-video) tool, which is designed to simplify the creation of
Multiple Sclerosis Drugs Market
Global Multiple Sclerosis Drugs Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. Get a Sample Copy of the Report at - https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/100386 Multiple Sclerosis (MS) is an immune-mediated disease affecting the central nervous system. It is characterized by demyelination, inflammation, degenerative changes such as progressive brain and spinal cord atrophy and neuroaxonal
Massive Multiple Input Multiple Output (MIMO) Market May Set New Growth Story
A Latest intelligence report published by MR Forecast with title "Global Massive Multiple Input Multiple Output (MIMO) Market Outlook to 2032. A detailed study accumulated to offer Latest insights about acute features of the Massive Multiple Input Multiple Output (MIMO) market. This report provides a detailed overview of key factors in the Global Massive Multiple Input Multiple Output (MIMO) Market and factors such as driver, restraint, past and current trends,
Multiple Sclerosis Drugs Market - Progressing Towards a Cure: Advancing Multiple …
Newark, New Castle, USA: The "Multiple Sclerosis Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Multiple Sclerosis Drugs Market: https://www.growthplusreports.com/report/multiple-sclerosis-drugs-market/7983 This latest report researches the industry structure,
Multiple Sclerosis Drugs Market - Empowering Resilience, Embracing Possibilities …
Newark, New Castle, USA - new report, titled Multiple Sclerosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Multiple Sclerosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Multiple Sclerosis Drugs market. The report offers an overview of
Massive MIMO (Multiple-input multiple-output) Market 2022-2028 | Detailed Report
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Massive MIMO (Multiple-input multiple-output) industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Massive MIMO (Multiple-input multiple-output) market survey report has been prepared by conducting market research in a systematic manner. Moreover, the Massive MIMO (Multiple-input multiple-output)